Inactive Instrument

Insiders Epizyme, Inc.

Equities

EPZM

US29428V1044

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Epizyme Announces Management Changes	22-08-12	CI
Epizyme, Inc. Appoints Grant Bogle as Chief Executive Officer	22-08-12	CI
French Biotechnology Company Onxeo Names Chair as President/CEO	22-04-07	MT
Epizyme Chief Medical and Development Officer Shefali Agarwal Resigns	22-04-06	MT
Shefali Agarwal Resigns from Epizyme, Inc., Effective April 6, 2022	22-04-06	CI
Epizyme Doses First Patient In Phase 3 Study On Potential Lymphoma Treatment, Names New COO	22-03-15	MT
Epizyme, Inc. Appoints Jerald Korn as Chief Operating Officer	22-03-15	CI
Insider Buy: Epizyme	22-02-02	MT
Epizyme Announces Board Appointments	21-11-18	CI
Epizyme, Inc. Announces Resignation of Matthew Ros as Executive Vice President, Chief Strategy and Business Officer	21-10-29	CI
Epizyme, Inc. Announces Management Changes	21-08-09	CI
Epizyme, Inc. Announces Resignation of Paolo Tombesi as the Chief Financial Officer Effective July 16, 2021	21-06-28	CI
Epizyme, Inc. Announces That Matthew E. Ros Will Serve as Principal Financial Officer, Effective July 16, 2021	21-06-28	CI
Insider Trends: Insider Purchase Continues Epizyme Positive Trend	21-03-29	MT
Epizyme, Inc. Promotes Dr. Shefali Agarwal to Executive Vice President and Chief Medical and Development Officer	21-02-23	CI
Epizyme, Inc. Announces Executive Promotions	20-11-06	CI
Epizyme, Inc. Announces Resignation of Richard F. Pops from the Board of Directors	20-04-03	CI
Epizyme, Inc. Appoints Jeffery Kutok as Chief Scientific Officer	20-03-20	CI
Epizyme, Inc. Enters into Loan Agreement; Elects Pablo Legorreta to the Board as Class III Director	19-11-04	CI
Epizyme, Inc. Appoints Mark De Rosch to Chief Regulatory Officer	19-10-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Epizyme, Inc.

Equities

EPZM

US29428V1044

Insiders

Filters